Monoclonal gammopathy of undetermined significance (MGUS) is commonly diagnozed in the general population, particularly the elderly. The condition carries a risk of progression to myeloma or other lymphoproliferative disorders and, thus, warrants regular follow-up. MGUS patients can be risk-stratified based on both the amount and type of the monoclonal protein and light-chain ratio.
Key Words
Monoclonal gammopathy of undetermined significance, progression, risk factors